Overcoming Regulatory Aversion to Novel Methods of Evidence Generation
Clinical Pharmacology and Therapeutics - United States
doi 10.1002/cpt.1711
Full Text
Open PDFAbstract
Available in full text
Categories
Date
November 30, 2019
Authors
Publisher
Wiley